Placental pathology in smoking and non-smoking preeclamptic women

References

• Faye-Petersen J. Handbook of placental pathology, 2nd ed. London: Tailor & Francis, Informa Health Care; 2006
   Google Scholar
• Sato Y, Benirschke K, Marutsuka K, et al. Associations of intrauterine growth restriction with placental pathological factors, maternal factors and fetal factors; clinicopathological findings of 257 Japanese cases. Histol Histopathol 2013;28:127–32
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99
   PubMed Web of Science ®Google Scholar
• Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol 1996;20:115–26
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Althabe F, Belizan JM, Kafury-Goeta AC. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol 1999;181:1026–35
   PubMed Web of Science ®Google Scholar
• Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. The adverse effects of maternal smoking on the human placenta: a review. Placenta 2005;26:S81–6
   PubMed Web of Science ®Google Scholar
• England L, Zhang J. Smoking and risk of preeclampsia: a systematic review. Front Biosci 2007;12:2471–83
   PubMed Web of Science ®Google Scholar
• Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem 2013;153:13–19
   PubMed Web of Science ®Google Scholar
• Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998;97:645–50
   PubMed Web of Science ®Google Scholar
• Wang B, Cheheltani R, Rosano J, et al. Targeted delivery of VEGF to treat myocardial infarction. Adv Exp Med Biol 2013;765:307–14
   PubMed Web of Science ®Google Scholar
• Vinnars MT, Nasiell J, Ghazi S, et al. The severity of clinical manifestations in preeclampsia correlates with the amount of placental infarction. Acta Obstet Gynecol Scand 2011;90:19–25
   PubMed Web of Science ®Google Scholar
• ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 2002;99:159–67
   PubMed Web of Science ®Google Scholar
• Eik-Nes SH, Grottum P, Persson PH, Marsal K. Prediction of fetal growth deviation by ultrasonic biometry. I. Methodology. Acta Obstet Gynecol Scand 1982;61:53–8
   PubMed Web of Science ®Google Scholar
• Roberts DJ, Post MD. The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 2008;61:1254–60
   PubMed Web of Science ®Google Scholar
• Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol 2006;108:1005–16
   PubMed Web of Science ®Google Scholar
• Staff AC, Dechend R, Pijnenborg R. Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension 2010;56:1026–34
   PubMed Web of Science ®Google Scholar
• Redman CW, Tannetta DS, Dragovic RA, et al. Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 2012;33:S48–54
   PubMed Web of Science ®Google Scholar
• Lee ES, Oh MJ, Jung JW, et al. The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia. J Korean Med Sci 2007;22:94–8
   PubMed Web of Science ®Google Scholar
• Belgore FM, Lip GY, Blann AD. Vascular endothelial growth factor and its receptor, Flt-1, in smokers and non-smokers. Br J Biomed Sci 2000;57:207–13
   PubMed Web of Science ®Google Scholar
• Schmidt-Lucke C, Belgore F, Reinhold D, et al. Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers. Int J Cardiol 2005;100:207–12
   PubMed Web of Science ®Google Scholar
• Kahn SR, Almeida ND, McNamara H, et al. Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control study. BMC Pregnan Childbirth 2011;11:91
   PubMed Web of Science ®Google Scholar
• Boisrame T, Sananes N, Fritz G, et al. Placental abruption: risk factors, management and maternal-fetal prognosis. Cohort study over 10 years. Eur J Obstet Gynecol Reprod Biol 2014;179:100–4
   PubMed Web of Science ®Google Scholar
• Miller EC, Cao H, Wen SW, et al. The risk of adverse pregnancy outcomes is increased in preeclamptic women who smoke compared with nonpreeclamptic women who do not smoke. Am J Obstet Gynecol 2010;203:334.e331–8
   Web of Science ®Google Scholar
• Pipkin FB. Smoking in moderate/severe preeclampsia worsens pregnancy outcome, but smoking cessation limits the damage. Hypertension 2008;51:1042–6
   PubMed Web of Science ®Google Scholar